Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets
Publications
Télécharger-
2024Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms, Nature Communications, 2024, 15 (1), pp.2414. ⟨10.1038/s41467-024-46677-y⟩.
-
2023An original potentiating mechanism revealed by the cryo-EM structures of the human α7 nicotinic receptor in complex with nanobodies., Nat Commun 2023 Sep; 14(1): 5964.
-
2023Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor., Cell Mol Life Sci 2023 May; 80(6): 164.
-
2023Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases., Antimicrob Agents Chemother. .
-
2022Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein., J Biol Chem 2022 Jan; 298(1): 101290.
-
2020Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors., EMBO Mol Med 2020 Apr; 12(4): e11298.
-
2018A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation., Blood 2018 Sep; 132(11): 1193-1197.
-
2018Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor., Haematologica 2018 Apr; 103(4): 728-737.
-
2017A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation-Brief Report., Arterioscler Thromb Vasc Biol 2017 Sep; 37(9): 1736-1740.
-
2017Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions., Blood 2017 Apr; 129(17): 2443-2454.
-
+Voir la liste complète de publications